Israel - hebraico - Ministry of Health

j-c health care ltd - pimozide - טבליה - pimozide 4 mg - pimozide - pimozide - neuroleptic.

Israel - hebraico - Ministry of Health

j-c health care ltd - cinnarizine - טבליה - cinnarizine 25 mg - cinnarizine - cinnarizine - symptomatic treatment of nausea and vertigo due to meniere's disease and other labyrinthine disturbances and for travel sickness.

Israel - hebraico - Ministry of Health

lidorr elements ltd - praziquantel; pyrantel embonate - טבליה - praziquantel 20 mg; pyrantel embonate 230 mg

Israel - hebraico - Ministry of Health

lidorr elements ltd - febantel; pyrantel embonate - תרחיף - febantel 1.5 g / 100 ml; pyrantel embonate 1.44 g / 100 ml

Israel - hebraico - Ministry of Health

a.veterinary supply ltd - fenbendazole; praziquantel - טבליה - fenbendazole 500 mg; praziquantel 50 mg

Israel - hebraico - Ministry of Health

megapharm ltd - sulthiame - טבליות מצופות פילם - sulthiame 200 mg - sultiame - sultiame - treatment of epilepsy in adults and in treatment of the so called focal benign epilepsy of children, when other medication was not adequate.

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 25 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 50 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 100 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 100 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .